Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar
Clinical trial NCT00594347 · COMPLETED
Trial details
- NCT number
- NCT00594347
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-03-01
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.